These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Temporal trends in antiplatelet/antithrombotic use in acute coronary syndromes and in-hospital major bleeding complications. Motivala AA; Tamhane U; Saab F; Li J; Rogers EK; Froehlich J; Moscucci M; Eagle KA; Gurm HS Am J Cardiol; 2007 Nov; 100(9):1359-63. PubMed ID: 17950790 [TBL] [Abstract][Full Text] [Related]
23. [Future developments in the therapy of acute ST segment elevation myocardial infarction]. Moser M; Bode C Herz; 2005 Dec; 30(8):704-9. PubMed ID: 16331365 [TBL] [Abstract][Full Text] [Related]
24. Strategies for optimizing outcomes in the NSTE-ACS patient The CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report. Cohen M; Diez J; Fry E; Rao SV; Ferguson JJ; Zidar J; Levine G; Shani J J Invasive Cardiol; 2006 Dec; 18(12):617-39. PubMed ID: 17197714 [TBL] [Abstract][Full Text] [Related]
25. Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction. Manoukian SV Am J Cardiol; 2009 Sep; 104(5 Suppl):9C-15C. PubMed ID: 19695355 [TBL] [Abstract][Full Text] [Related]
26. The evolving role of glycoprotein IIb/IIIa inhibitor therapy in contemporary care of acute coronary syndrome patients. Tricoci P; Peterson ED J Interv Cardiol; 2006 Oct; 19(5):449-55. PubMed ID: 17020570 [TBL] [Abstract][Full Text] [Related]
28. [Percutaneous coronary interventions in elderly patients: clinical indications and adjunctive medical treatment. The Italian Drug Evaluation in Angioplasty (IDEA) study]. Bossi I; Piccaluga E; Scatturin M; Corvaja N; Pasquetto G; Steffanon L; Oberhollenzer R; Colombo P; Bolognese L; Savonitto S G Ital Cardiol (Rome); 2006 Feb; 7(2):136-44. PubMed ID: 16532725 [TBL] [Abstract][Full Text] [Related]
29. High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome. Cuisset T; Frere C; Quilici J; Barbou F; Morange PE; Hovasse T; Bonnet JL; Alessi MC J Thromb Haemost; 2006 Mar; 4(3):542-9. PubMed ID: 16371119 [TBL] [Abstract][Full Text] [Related]
30. Results from clinical trials on ST-elevation myocardial infarction in a historic perspective with some pathophysiological aspects. Otterstad JE; Brosstad F Scand Cardiovasc J; 2003 Dec; 37(6):316-23. PubMed ID: 14668180 [TBL] [Abstract][Full Text] [Related]
36. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody. Roldán V; Marín F Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516 [No Abstract] [Full Text] [Related]
37. Intensity of antiplatelet therapy in patients with acute coronary syndromes and percutaneous coronary intervention: the promise of prasugrel? Wiviott SD Cardiol Clin; 2008 Nov; 26(4):629-37. PubMed ID: 18929236 [TBL] [Abstract][Full Text] [Related]
38. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents. Spinler SA Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808 [TBL] [Abstract][Full Text] [Related]
39. Adjunctive pharmacotherapy before percutaneous coronary intervention in non-ST-elevation acute coronary syndromes: the role of modulating inflammation. Kereiakes DJ Circulation; 2003 Oct; 108(16 Suppl 1):III22-7. PubMed ID: 14605016 [TBL] [Abstract][Full Text] [Related]
40. Angioplasty in severe heart attack. Anesthesia and general management. Ranucci M Minerva Anestesiol; 2002 Apr; 68(4):192-5. PubMed ID: 12024081 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]